The biotechnology companies formed a research alliance combining experimental capabilities with artificial intelligence platforms for therapeutic candidate identification. TOKYO, March 13, 2026 ...

PRISM BioLab Co., Ltd. ("PRISM") and Receptor.AI Inc. today announced that they have entered into a drug discovery collaboration agreement (the "Collaboration") to develop an integrated, AI-navigated, ...

Aphranel, a China-origin regenerative medical aesthetics brand under the company SHANGHAI MOYANG BIOTECHNOLOGY, has been named to the Third Forbes China Beauty 100 list, published by Forbes China, ...

Lilly is warning the public that tirzepatide mixed with B12 is creating an impurity with “unknown effects” in humans.

Mestag Therapeutics ('Mestag”), a biotech company harnessing fibroblast immunology for the benefit of patients with inflammatory disease and cancer, announced today that it will be presenting a poster ...

The endometriosis market is expected to grow steadily over the forecast period (2026--2036), driven by rising disease awareness, improving diagnosis rates, and advancements in noninvasive diagnostic ...

YCT-529 inhibits retinoic acid receptor alpha to suppress sperm production reversibly. Currently in Phase 1b/2a trials, the compound has shown promise in preclinical models and aims to expand ...

Abbott (NYSE:ABT) today announced results from a trial demonstrating better glucose outcomes for users of continuous glucose monitors (CGMs).

According to a new team-up between Eisai and Pokémon, when it comes to healthy sleep habits, people of all ages have gotta ...

At four months, people using Libre technology had a 0.6% greater reduction in HbA1c and 2.5 more hours a day in the healthy range vs. those using finger pricking1,2Improvements were participant-led, ...

ImmunoForge Co., Ltd., a biopharmaceutical company developing treatments for rare diseases, announced that they will participate in Bio-Europe Spring 2026, held in Lisbon, Portugal, from March 23rd to ...

NEW YORK, March 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Snap, Inc. ("Snap" or the "Company") (NYSE: SNAP). Such investors are advised to contact ...